Anfossi, S., Giordano, A., Gao, H., Cohen, E.N., Tin, S., Wu, Q., et al. (2014) High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS ONE, 9, e83113.

P63在HER2低表达乳腺癌中的表达及临床意义
Expression and Clinical Significance of P63 in HER2 Low-Expression Breast Cancer

冯 月, 张立雪, 欧江华   

临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122621, December 5 2023

PIK3CA基因突变与HR阳性且HER2阴性乳腺癌的关系
The Relationship between PIK3CA Mutation and Hormone Receptor Positive and HER2 Negative Breast Cancer

依合里曼·买买提, 梁丽萍, 江志民, 马晓梅   

临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132384, February 23 2023

血液学炎性指标与乳腺癌预后相关性的研究进展
Research Progress on the Relationship between Hematological Inflammatory Indexes and Prognosis of Breast Cancer

高 珊, 易慕华, 王俊杰    国家自然科学基金支持

临床医学进展Vol.12 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.12121709, December 28 2022

卡培他滨单药或联合方案治疗转移性乳腺癌临床疗效观察
Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

李 杰, 李凤虎, 常建英, 李杰慧, 袁 佳, 刘诗苑, 冉 立    科研立项经费支持

临床医学进展Vol.4 No.4, 全文下载: PDF HTML DOI:10.12677/ACM.2014.44016, December 31 2014

炎性乳腺癌的诊治现状
Current Status of Diagnosis and Management of Inflammatory Breast Cancer

加德拉·阿勒马斯别克, 甫拉提·吾瓦力汗   

临床医学进展Vol.13 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13112602, November 29 2023

曲妥珠单抗靶向治疗HER2阳性乳腺癌的研究进展
Research Progress of Trastuzumab Targeted Therapy for HER2-Positive Breast Cancer

胥世霜   

临床医学进展Vol.13 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1371686, July 27 2023